Table 4.

Pearson correlation analysis results.

Variable	Gender	Knowledge	Perceived benefits	Perceived susceptibility	Perceived severity	Perceived barriers	Vaccine concerns	Perceived inconvenience	HPV vaccinated
Gender	1	−0.066*	0.017	−0.066*	0.081**	−0.104**	0.019	0.015	0.042
Knowledge	−0.066*	1	0.374**	0.267**	0.284**	−0.296**	−0.286**	−0.295**	0.405**
Perceived benefits	0.017	0.374**	1	0.615**	0.654**	0.046	−0.065*	−0.073*	0.370**
Perceived susceptibility	−0.066*	0.267**	0.615**	1	0.623**	0.178**	0.101**	0.025	0.312**
Perceived severity	0.081**	0.284**	0.654**	0.623**	1	0.169**	0.053	−0.015	0.355**
Perceived barriers	−0.104**	−0.296**	0.046	0.178**	0.169**	1	0.699**	0.639**	−0.145**
Vaccine concerns	0.019	−0.286**	−0.065*	0.101**	0.053	0.699**	1	0.794**	−0.053
Perceived inconvenience	0.015	−0.295**	−0.073*	0.025	−0.015	0.639**	0.794**	1	−0.134**
HPV vaccinated	0.042	0.405**	0.370**	0.312**	0.355**	−0.145**	−0.053	−0.134**	1

*p < 0.05, **p < 0.01. All correlation coefficients are reported with 95% CIs; effect sizes were categorized based on Cohen’s criteria. The vaccinated group is defined as participants who have received at least one dose of HPV vaccine.